All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @chloe.morgan.davis on TikTok · 8s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @chloe.morgan.davis's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Maybe not you're one of us
  2. 0:02Any fun, any fun, any fun

GLP-1 drugs and postpartum weight loss: what the science says

Chloe Davis

TikTok creator

319.4K viewsWatch on TikTok

Quick answer

This video contains no medical claims, drug references, or health recommendations of any kind. The creator posted body-positive postpartum content with a caption advocating for realistic expectations of postpartum recovery. No GLP-1 medications or weight management interventions were mentioned, implied, or endorsed.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For GLP-1 drugs and postpartum weight loss: what the science says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

GLP-1 drugs and postpartum weight loss: what the science says should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "GLP-1 drugs and postpartum weight loss: what the science says" from Chloe Davis. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: This video contains no medical claims, drug references, or health recommendations of any kind.

The reason this review is not generic is the source wording and the canonical claim label "glp1 justice for the regular postpartum bodies you just grew a hu." In this clip, the useful excerpt is: "Maybe not you're one of us Any fun, any fun, any fun" That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

ACOG formally extended postpartum care to up to 12 months in 2018, recognizing that the old 6-week recovery model was inadequate.
People who land here are usually comparing the GLP-1 social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GLP-1 social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

This video contains no medical claims, drug references, or health recommendations of any kind.

FormBlends verdict

GLP-1 social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • This video contains no medical claims, drug references, or health recommendations of any kind. The creator posted body-positive postpartum content with a caption advocating for realistic expectations of postpartum recovery. No GLP-1 medications or weight management interventions were mentioned, implied, or endorsed.
  • This video makes no medical claims and does not reference GLP-1 medications, weight loss drugs, or any health interventions.
  • ACOG formally extended postpartum care to up to 12 months in 2018, recognizing that the old 6-week recovery model was inadequate.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • This video makes no medical claims and does not reference GLP-1 medications, weight loss drugs, or any health interventions.
  • ACOG formally extended postpartum care to up to 12 months in 2018, recognizing that the old 6-week recovery model was inadequate.
  • A 2019 systematic review (Gjerdingen et al., Journal of Women's Health) found postpartum weight retention is highly individual and influenced by sleep, stress, breastfeeding, and pre-pregnancy BMI.
  • Matheson et al. (2020, Appetite) found that social media 'bounce back' pressure correlates with increased rates of disordered eating in postpartum individuals.
  • GLP-1 receptor agonists including semaglutide and tirzepatide are not currently approved for use during breastfeeding, and safety data in lactating individuals remains limited.
  • Body-positive postpartum content is not the same as medical advice, but the sentiment expressed here is consistent with what reproductive health research recommends: realistic timelines and reduced social pressure on new parents.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @chloe.morgan.davis actually say?

Almost nothing, medically speaking. The transcript captured from this video is essentially song lyrics or background audio: "Maybe not you're one of us / Any fun, any fun, any fun." The actual message is delivered visually and through the caption: "Justice for the regular postpartum bodies...you just grew a human inside you." There are no medical claims, no supplement recommendations, no weight-loss drug endorsements. This is a body-positive postpartum content post, full stop.

Given the video is categorized under GLP-1 receptor agonists, it is worth being transparent: nothing in this video promotes, recommends, or references semaglutide, tirzepatide, liraglutide, or any other GLP-1 medication. The creator is sharing a sentiment, not a health claim.

Does the science back this up?

The underlying premise, that postpartum bodies deserve grace and realistic expectations, is actually well-supported by research. The postpartum period involves significant physiological changes that persist well beyond six weeks, and unrealistic recovery timelines cause measurable psychological harm.

A 2018 study by Dritsa et al. in Maternal and Child Health Journal found that body dissatisfaction in the postpartum period is strongly associated with elevated depressive symptoms and reduced quality of life. Separately, research by Cooney et al. (2021, BMC Pregnancy and Childbirth) documented that women consistently underestimate how long physical recovery from childbirth actually takes, often by months. The American College of Obstetricians and Gynecologists formally extended postpartum care guidelines in 2018 precisely because the old six-week model ignored ongoing physical and mental recovery needs. So the sentiment that postpartum bodies are "regular" and deserve patience is not just feel-good messaging. It reflects clinical reality.

What did they get wrong (or right)?

There is genuinely nothing to fact-check as wrong here. The creator made no specific health claims. What she got right, implicitly, is the framing that postpartum recovery is not linear and that social media pressure around "bouncing back" is harmful.

The research backs this up harder than most people realize. A 2019 systematic review by Gjerdingen et al. in Journal of Women's Health found that postpartum weight retention varies enormously between individuals and is influenced by factors including breastfeeding status, sleep deprivation, socioeconomic stress, and pre-pregnancy BMI. There is no universal postpartum body trajectory. The "bounce back" narrative that dominates social media has no scientific basis and correlates with increased rates of disordered eating postpartum, per Matheson et al. (2020, Appetite). The creator is pushing back against something that research suggests is genuinely harmful.

What should you actually know?

If you landed here because you are postpartum and wondering about GLP-1 medications for weight management, that is a separate and more complicated conversation than this video addresses. GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) are not currently approved for use during breastfeeding, and safety data in lactating individuals is limited. That is not a small caveat.

What is worth knowing:

  • The postpartum period is now recognized clinically as lasting up to one year, not six weeks.
  • Hormonal shifts, sleep deprivation, and metabolic changes during this period are significant and affect weight regulation independently of diet or exercise.
  • Any weight management intervention in the postpartum period, including GLP-1 medications, should involve a licensed provider who knows your full clinical picture, including feeding status.
  • Body-positive content is not the same as medical advice, but the sentiment expressed here does not contradict clinical evidence. It actually aligns with what reproductive health researchers recommend: realistic timelines and reduced social pressure.

This video is not making a medical claim. It is making a social one. And on that front, the evidence is largely on its side.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Chloe Davis · TikTok creator

319.4K views on this video

Justice for the regular postpartum bodies…you just grew a human inside you 🫶🏻#4thtrimester #postpartum #postpartumjourney #mom #postpartumbody

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about this video makes no medical claims?

This video makes no medical claims and does not reference GLP-1 medications, weight loss drugs, or any health interventions.

What does the video say about acog formally extended postpartum care to up to 12 months?

ACOG formally extended postpartum care to up to 12 months in 2018, recognizing that the old 6-week recovery model was inadequate.

What does the video say about a 2019 systematic review (gjerdingen et al., journal of women's?

A 2019 systematic review (Gjerdingen et al., Journal of Women's Health) found postpartum weight retention is highly individual and influenced by sleep, stress, breastfeeding, and pre-pregnancy BMI.

What does the video say about matheson et al. (2020, appetite) found?

Matheson et al. (2020, Appetite) found that social media 'bounce back' pressure correlates with increased rates of disordered eating in postpartum individuals.

What does the video say about glp-1 receptor agonists including semaglutide?

GLP-1 receptor agonists including semaglutide and tirzepatide are not currently approved for use during breastfeeding, and safety data in lactating individuals remains limited.

What does the video say about body-positive postpartum content?

Body-positive postpartum content is not the same as medical advice, but the sentiment expressed here is consistent with what reproductive health research recommends: realistic timelines and reduced social pressure on new parents.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Chloe Davis, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.